<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Adenuric; Febuxostat" /><meta name="IX" content="Adenuric; Febuxostat" /><title>Adenuric®: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP6674-adenuric.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP6674-adenuric.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP6674-adenuric.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 08 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP6372-musculoskeletal-and-joint-diseases.htm">10 Musculoskeletal and joint diseases</a> &gt; <a href="PHP6373-drugs-used-in-rheumatic-diseases-and-gout.htm">10.1 Drugs used in rheumatic diseases and gout</a> &gt; <a href="PHP6660-gout-and-cytotoxic-induced-hyperuricaemia.htm">10.1.4 Gout and cytotoxic-induced hyperuricaemia</a> &gt; <a href="PHP6664-long-term-control-of-gout.htm">Long-term control of gout</a> &gt; <a href="PHP6673-febuxostat.htm">FEBUXOSTAT</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP6669-allopurinol.htm" title="Previous: ALLOPURINOL">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP6675-probenecid.htm" title="Next: PROBENECID">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a309010.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Febuxostat</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Miscellaneous Therapeutic Agents 92:00 &gt; Antigout Agents 92:16</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/20979-y.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Febuxostat</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: F &gt; Interactions of Febuxostat</p></div></li></ul><ul><li><h3>British National Formulary (2)</h3></li><li><a href="PHP6664-long-term-control-of-gout.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Long-term control of gout</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 10 Musculoskeletal and joint diseases &gt; 10.1 Drugs used in rheumatic diseases and gout &gt; 10.1.4 Gout and cytotoxic-induced hyperuricaemia</p></div></li><li><a href="PHP6673-febuxostat.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">FEBUXOSTAT</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 10 Musculoskeletal and joint diseases &gt; 10.1 Drugs used in rheumatic diseases and gout &gt; 10.1.4 Gout and cytotoxic-induced hyperuricaemia &gt; Long-term control of gout</p></div></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/20979-y.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Febuxostat</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antigout Drugs &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/03948.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Febuxostat</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; F &gt; FE</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E0E0E6E3E0R0D285.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Febuxostat</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; F</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>FEBUXOSTAT</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int1178-febuxostat.htm">Febuxostat</a>).</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">treatment of chronic hyperuricaemia in gout (but see also <a title="BNF:target-block: Febuxostat NICE guidance" href="PHP6664-long-term-control-of-gout.htm#PHP6667">NICE guidance</a>)</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">administer prophylactic NSAID (<em>not</em> aspirin or salicylates) or colchicine for at least 6 months after starting febuxostat to avoid precipitating an acute attack; transplant recipients; monitor liver function tests before and periodically during treatment as indicated; thyroid disorders; ischaemic heart disease; congestive heart failure; <strong>interactions:</strong> Appendix 1 (febuxostat)</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Contra-indications </h2> <p class="cT">not a treatment for acute gout but continue if attack develops when already receiving febuxostat, and treat attack separately (see <a title="BNF:monograph-family: Long-term control of gout" href="PHP6664-long-term-control-of-gout.htm">notes above</a>)</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Hepatic impairment </h2> <p class="cT">max. 80 mg daily in mild impairment; no dose information available in moderate or severe impairment</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Renal impairment </h2> <p class="cT">use with caution if eGFR less than 30 mL/minute/1.73 m<sup>2</sup>—no information available</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">manufacturer advises avoid—limited information available</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">manufacturer advises avoid—present in milk in <em>animal</em> studies</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">gastro-intestinal disturbances, abnormal liver function tests; headache; rash; <em>less commonly</em> taste disturbances, increased appetite; hypertension, oedema, flushing; dizziness, paraesthesia, drowsiness; influenza-like symptoms; haematuria, nephrolithiasis, increased urinary frequency, decreased libido; myalgia; dermatitis, pruritus, urticaria; <em>rarely</em> thirst, palpitation, asthenia, nervousness, insomnia, and renal impairment</p></div><div class="cI"><p class="cAE">MHRA/CHM advice</p><h3 class="cT">Serious hypersensitivity reactions (June 2012)</h3><p id="PHP18479">There have been rare but serious reports of hypersensitivity reactions, including Stevens-Johnson syndrome and acute anaphylactic shock with febuxostat. Patients should be advised of the signs and symptoms of severe hypersensitiviy; febuxostat must be stopped immediately if these occur (early withdrawal is associated with a better prognosis), and must not be restarted in patients who have ever developed a hypersensitivity reaction to febuxostat. Most cases occur during the first month of treatment; a prior history of hypersensitivity to allopurinol and/or renal disease may indicate potential hypersensitivity to febuxostat.</p></div></div><div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul><li><p><span class="cP">adult</span> over 18 years, 80 mg once daily, if after 2–4 weeks serum uric acid greater than 6 mg/100 mL, increase to 120 mg once daily</p></li></ul></div></div></div><div id="pS"><p>Sub-sections</p><div id="PHP6674-adenuric" style="margin: 0 0 0 20px;"><h1 class="title">Adenuric® <span>(<a href="PHP10005-index-of-manufacturers.htm#PHP10238">Menarini</a>)</span><span> <a title="Report adverse reaction(s)" href="PHP10518-yellow-card-scheme.htm"><img class="cD" src="images/blacktri_s.png" alt="Report adverse reaction(s)" /></a> <img src="images/pom_l.png" alt="Prescription only medicine" /></span></h1><div class="cU"><p><strong>Tablets</strong>, both yellow, f/c, febuxostat 80 mg, net price 28-tab pack = £24.36; 120 mg 28-tab pack = £24.36</p></div></div></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP6669-allopurinol.htm">Previous: ALLOPURINOL</a> | <a class="top" href="PHP6674-adenuric.htm#">Top</a> | <a accesskey="]" href="PHP6675-probenecid.htm">Next: PROBENECID</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>